0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Veterinary Oncology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-17E5897
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Veterinary Oncology Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Veterinary Oncology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-17E5897
Report
October 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Oncology - Market Size

According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021.

Veterinary Oncology - Market

Veterinary Oncology - Market

Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals.
The global market for Veterinary Oncology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 115%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Oncology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Veterinary Oncology by region & country, by Type, and by Application.
The Veterinary Oncology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Oncology.
Market Segmentation

Scope of Veterinary Oncology - Market Report

Report Metric Details
Report Name Veterinary Oncology - Market
Accounted market size in 2021 $ 38.3 billion
Base Year 2021
Segment by Type:
  • Surgery
  • Radiology
  • Chemotherapy
  • Immunotherapy
  • Others (Combination Therapy, Targeted Therapy)
Segment by Application
  • Canine
  • Feline
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company PetCure Oncology, Accuray Incorporated, Varian Medical Systems, Boehringer Ingelheim, Elanco, Zoetis Karyopharm Therapeutics, Inc., One Health, Regeneus Ltd., Nippon Zenyaku Kogyo Co., Ltd., Morphogenesis, Inc., Karyopharm Therapeutics, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Veterinary Oncology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Veterinary Oncology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Veterinary Oncology in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Veterinary Oncology - Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Veterinary Oncology - Market report?

Ans: The main players in the Veterinary Oncology - Market are PetCure Oncology, Accuray Incorporated, Varian Medical Systems, Boehringer Ingelheim, Elanco, Zoetis Karyopharm Therapeutics, Inc., One Health, Regeneus Ltd., Nippon Zenyaku Kogyo Co., Ltd., Morphogenesis, Inc., Karyopharm Therapeutics, Inc.

What are the Application segmentation covered in the Veterinary Oncology - Market report?

Ans: The Applications covered in the Veterinary Oncology - Market report are Canine, Feline

What are the Type segmentation covered in the Veterinary Oncology - Market report?

Ans: The Types covered in the Veterinary Oncology - Market report are Surgery, Radiology, Chemotherapy, Immunotherapy, Others (Combination Therapy, Targeted Therapy)

Recommended Reports

Veterinary Equipment

Animal Health

Pet Nutrition

1 Market Overview
1.1 Veterinary Oncology Product Introduction
1.2 Global Veterinary Oncology Market Size Forecast
1.3 Veterinary Oncology Market Trends & Drivers
1.3.1 Veterinary Oncology Industry Trends
1.3.2 Veterinary Oncology Market Drivers & Opportunity
1.3.3 Veterinary Oncology Market Challenges
1.3.4 Veterinary Oncology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary Oncology Players Revenue Ranking (2023)
2.2 Global Veterinary Oncology Revenue by Company (2019-2024)
2.3 Key Companies Veterinary Oncology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Veterinary Oncology Product Offered
2.5 Key Companies Time to Begin Mass Production of Veterinary Oncology
2.6 Veterinary Oncology Market Competitive Analysis
2.6.1 Veterinary Oncology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Veterinary Oncology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Oncology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Surgery
3.1.2 Radiology
3.1.3 Chemotherapy
3.1.4 Immunotherapy
3.1.5 Others (Combination Therapy, Targeted Therapy)
3.2 Global Veterinary Oncology Sales Value by Type
3.2.1 Global Veterinary Oncology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Veterinary Oncology Sales Value, by Type (2019-2030)
3.2.3 Global Veterinary Oncology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Canine
4.1.2 Feline
4.2 Global Veterinary Oncology Sales Value by Application
4.2.1 Global Veterinary Oncology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Oncology Sales Value, by Application (2019-2030)
4.2.3 Global Veterinary Oncology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Veterinary Oncology Sales Value by Region
5.1.1 Global Veterinary Oncology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Veterinary Oncology Sales Value by Region (2019-2024)
5.1.3 Global Veterinary Oncology Sales Value by Region (2025-2030)
5.1.4 Global Veterinary Oncology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Veterinary Oncology Sales Value, 2019-2030
5.2.2 North America Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Veterinary Oncology Sales Value, 2019-2030
5.3.2 Europe Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Veterinary Oncology Sales Value, 2019-2030
5.4.2 Asia Pacific Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Veterinary Oncology Sales Value, 2019-2030
5.5.2 South America Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Veterinary Oncology Sales Value, 2019-2030
5.6.2 Middle East & Africa Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary Oncology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Veterinary Oncology Sales Value
6.3 United States
6.3.1 United States Veterinary Oncology Sales Value, 2019-2030
6.3.2 United States Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Veterinary Oncology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Veterinary Oncology Sales Value, 2019-2030
6.4.2 Europe Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Veterinary Oncology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Veterinary Oncology Sales Value, 2019-2030
6.5.2 China Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Veterinary Oncology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Veterinary Oncology Sales Value, 2019-2030
6.6.2 Japan Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Veterinary Oncology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Veterinary Oncology Sales Value, 2019-2030
6.7.2 South Korea Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Veterinary Oncology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary Oncology Sales Value, 2019-2030
6.8.2 Southeast Asia Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Veterinary Oncology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Veterinary Oncology Sales Value, 2019-2030
6.9.2 India Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Veterinary Oncology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 PetCure Oncology
7.1.1 PetCure Oncology Profile
7.1.2 PetCure Oncology Main Business
7.1.3 PetCure Oncology Veterinary Oncology Products, Services and Solutions
7.1.4 PetCure Oncology Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.1.5 PetCure Oncology Recent Developments
7.2 Accuray Incorporated
7.2.1 Accuray Incorporated Profile
7.2.2 Accuray Incorporated Main Business
7.2.3 Accuray Incorporated Veterinary Oncology Products, Services and Solutions
7.2.4 Accuray Incorporated Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.2.5 Accuray Incorporated Recent Developments
7.3 Varian Medical Systems
7.3.1 Varian Medical Systems Profile
7.3.2 Varian Medical Systems Main Business
7.3.3 Varian Medical Systems Veterinary Oncology Products, Services and Solutions
7.3.4 Varian Medical Systems Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.3.5 Boehringer Ingelheim Recent Developments
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Profile
7.4.2 Boehringer Ingelheim Main Business
7.4.3 Boehringer Ingelheim Veterinary Oncology Products, Services and Solutions
7.4.4 Boehringer Ingelheim Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.4.5 Boehringer Ingelheim Recent Developments
7.5 Elanco
7.5.1 Elanco Profile
7.5.2 Elanco Main Business
7.5.3 Elanco Veterinary Oncology Products, Services and Solutions
7.5.4 Elanco Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.5.5 Elanco Recent Developments
7.6 Zoetis Karyopharm Therapeutics, Inc.
7.6.1 Zoetis Karyopharm Therapeutics, Inc. Profile
7.6.2 Zoetis Karyopharm Therapeutics, Inc. Main Business
7.6.3 Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Products, Services and Solutions
7.6.4 Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.6.5 Zoetis Karyopharm Therapeutics, Inc. Recent Developments
7.7 One Health
7.7.1 One Health Profile
7.7.2 One Health Main Business
7.7.3 One Health Veterinary Oncology Products, Services and Solutions
7.7.4 One Health Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.7.5 One Health Recent Developments
7.8 Regeneus Ltd.
7.8.1 Regeneus Ltd. Profile
7.8.2 Regeneus Ltd. Main Business
7.8.3 Regeneus Ltd. Veterinary Oncology Products, Services and Solutions
7.8.4 Regeneus Ltd. Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.8.5 Regeneus Ltd. Recent Developments
7.9 Nippon Zenyaku Kogyo Co., Ltd.
7.9.1 Nippon Zenyaku Kogyo Co., Ltd. Profile
7.9.2 Nippon Zenyaku Kogyo Co., Ltd. Main Business
7.9.3 Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Products, Services and Solutions
7.9.4 Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.9.5 Nippon Zenyaku Kogyo Co., Ltd. Recent Developments
7.10 Morphogenesis, Inc.
7.10.1 Morphogenesis, Inc. Profile
7.10.2 Morphogenesis, Inc. Main Business
7.10.3 Morphogenesis, Inc. Veterinary Oncology Products, Services and Solutions
7.10.4 Morphogenesis, Inc. Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.10.5 Morphogenesis, Inc. Recent Developments
7.11 Karyopharm Therapeutics, Inc.
7.11.1 Karyopharm Therapeutics, Inc. Profile
7.11.2 Karyopharm Therapeutics, Inc. Main Business
7.11.3 Karyopharm Therapeutics, Inc. Veterinary Oncology Products, Services and Solutions
7.11.4 Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue (US$ Million) & (2019-2024)
7.11.5 Karyopharm Therapeutics, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Veterinary Oncology Industrial Chain
8.2 Veterinary Oncology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary Oncology Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary Oncology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Veterinary Oncology Market Trends
    Table 2. Veterinary Oncology Market Drivers & Opportunity
    Table 3. Veterinary Oncology Market Challenges
    Table 4. Veterinary Oncology Market Restraints
    Table 5. Global Veterinary Oncology Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Veterinary Oncology Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Veterinary Oncology Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Veterinary Oncology Product Type
    Table 9. Key Companies Time to Begin Mass Production of Veterinary Oncology
    Table 10. Global Veterinary Oncology Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Oncology as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Veterinary Oncology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Veterinary Oncology Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Veterinary Oncology Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Veterinary Oncology Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Veterinary Oncology Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Veterinary Oncology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Veterinary Oncology Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Veterinary Oncology Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Veterinary Oncology Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Veterinary Oncology Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Veterinary Oncology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Veterinary Oncology Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Veterinary Oncology Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Veterinary Oncology Sales Value by Region (2019-2024) & (%)
    Table 27. Global Veterinary Oncology Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Veterinary Oncology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Veterinary Oncology Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Veterinary Oncology Sales Value, (2025-2030) & (US$ Million)
    Table 31. PetCure Oncology Basic Information List
    Table 32. PetCure Oncology Description and Business Overview
    Table 33. PetCure Oncology Veterinary Oncology Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Veterinary Oncology Business of PetCure Oncology (2019-2024)
    Table 35. PetCure Oncology Recent Developments
    Table 36. Accuray Incorporated Basic Information List
    Table 37. Accuray Incorporated Description and Business Overview
    Table 38. Accuray Incorporated Veterinary Oncology Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Veterinary Oncology Business of Accuray Incorporated (2019-2024)
    Table 40. Accuray Incorporated Recent Developments
    Table 41. Varian Medical Systems Basic Information List
    Table 42. Varian Medical Systems Description and Business Overview
    Table 43. Varian Medical Systems Veterinary Oncology Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Veterinary Oncology Business of Varian Medical Systems (2019-2024)
    Table 45. Varian Medical Systems Recent Developments
    Table 46. Boehringer Ingelheim Basic Information List
    Table 47. Boehringer Ingelheim Description and Business Overview
    Table 48. Boehringer Ingelheim Veterinary Oncology Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Veterinary Oncology Business of Boehringer Ingelheim (2019-2024)
    Table 50. Boehringer Ingelheim Recent Developments
    Table 51. Elanco Basic Information List
    Table 52. Elanco Description and Business Overview
    Table 53. Elanco Veterinary Oncology Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Veterinary Oncology Business of Elanco (2019-2024)
    Table 55. Elanco Recent Developments
    Table 56. Zoetis Karyopharm Therapeutics, Inc. Basic Information List
    Table 57. Zoetis Karyopharm Therapeutics, Inc. Description and Business Overview
    Table 58. Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Veterinary Oncology Business of Zoetis Karyopharm Therapeutics, Inc. (2019-2024)
    Table 60. Zoetis Karyopharm Therapeutics, Inc. Recent Developments
    Table 61. One Health Basic Information List
    Table 62. One Health Description and Business Overview
    Table 63. One Health Veterinary Oncology Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Veterinary Oncology Business of One Health (2019-2024)
    Table 65. One Health Recent Developments
    Table 66. Regeneus Ltd. Basic Information List
    Table 67. Regeneus Ltd. Description and Business Overview
    Table 68. Regeneus Ltd. Veterinary Oncology Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Veterinary Oncology Business of Regeneus Ltd. (2019-2024)
    Table 70. Regeneus Ltd. Recent Developments
    Table 71. Nippon Zenyaku Kogyo Co., Ltd. Basic Information List
    Table 72. Nippon Zenyaku Kogyo Co., Ltd. Description and Business Overview
    Table 73. Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Veterinary Oncology Business of Nippon Zenyaku Kogyo Co., Ltd. (2019-2024)
    Table 75. Nippon Zenyaku Kogyo Co., Ltd. Recent Developments
    Table 76. Morphogenesis, Inc. Basic Information List
    Table 77. Morphogenesis, Inc. Description and Business Overview
    Table 78. Morphogenesis, Inc. Veterinary Oncology Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Veterinary Oncology Business of Morphogenesis, Inc. (2019-2024)
    Table 80. Morphogenesis, Inc. Recent Developments
    Table 81. Karyopharm Therapeutics, Inc. Basic Information List
    Table 82. Karyopharm Therapeutics, Inc. Description and Business Overview
    Table 83. Karyopharm Therapeutics, Inc. Veterinary Oncology Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Veterinary Oncology Business of Karyopharm Therapeutics, Inc. (2019-2024)
    Table 85. Karyopharm Therapeutics, Inc. Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Veterinary Oncology Downstream Customers
    Table 89. Veterinary Oncology Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Veterinary Oncology Product Picture
    Figure 2. Global Veterinary Oncology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Veterinary Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 4. Veterinary Oncology Report Years Considered
    Figure 5. Global Veterinary Oncology Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Oncology Revenue in 2023
    Figure 7. Veterinary Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Surgery Picture
    Figure 9. Radiology Picture
    Figure 10. Chemotherapy Picture
    Figure 11. Immunotherapy Picture
    Figure 12. Others (Combination Therapy, Targeted Therapy) Picture
    Figure 13. Global Veterinary Oncology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Veterinary Oncology Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Canine
    Figure 16. Product Picture of Feline
    Figure 17. Global Veterinary Oncology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Veterinary Oncology Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Veterinary Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Veterinary Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Veterinary Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Veterinary Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Veterinary Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Veterinary Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Veterinary Oncology Sales Value (%), (2019-2030)
    Figure 30. United States Veterinary Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Veterinary Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Veterinary Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Veterinary Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Veterinary Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Veterinary Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Veterinary Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Veterinary Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Veterinary Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Veterinary Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Veterinary Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Veterinary Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Veterinary Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Veterinary Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Veterinary Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 51. Veterinary Oncology Industrial Chain
    Figure 52. Veterinary Oncology Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS